Article Information
History
- August 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xavier Charmetant1,*,
- Maxime Espi1,*,
- Thomas Barba1,
- Anne Ovize2,
- Emmanuel Morelon1,3,4 and
- Olivier Thaunat1,3,4,#
- 1CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, 21 avenue Tony Garnier, 69007 Lyon, France
- 2Eurofins Biomnis Laboratory, 69007 Lyon, France
- 3Hospices Civils de Lyon, Edouard Herriot Hospital, Department of Transplantation, Nephrology and Clinical Immunology, 5, place d’Arsonval, 69003 Lyon, France
- 4Claude Bernard University (Lyon 1), 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne France
- ↵#Correspondence to:
Olivier Thaunat MD, PhD, Service de Transplantation, Néphrologie et Immunologie Clinique, Hôpital Edouard Herriot, 5 Place d’Arsonval, 69003 Lyon, France, Phone: +33 472110170, Email: olivier.thaunat{at}chu-lyon.fr
↵* equal contributions
Posted August 30, 2021.
Predictive factors of response to 3rd dose of COVID-19 mRNA vaccine in kidney transplant recipients
